Plasma levels of sST2 in dengue subjects categorised by disease severities over time.

Dengue subjects (n = 90) classified based on WHO 2009 dengue classifications–dengue fever (n = 36), dengue with warning signs (n = 43) and severe dengue (n = 11); controls (n = 30) collected at one time point were included in the analysis of plasma sST2 levels at: (A) early phase; (B) critical phase; (C) early recovery phase; and (D) late recovery phase. Plasma sST2 concentrations were determined by serial dilution of a standard curve. Data are presented as median (horizontal line). P values by Kruskal Wallis tests. Abbreviation: sST2, soluble suppression of tumorigenicity 2.